Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cervical intraepithelial neoplasia lesions in women undergoing lesion surgical treatment (VACCIN): a multicentre, phase 4 randomised placebo-controlled trial in the Netherlands
Ralf L O van de Laar, Ward Hofhuis, Ruben G. Duijnhoven, Ruud L.M. Bekkers, H.P.M. Smedts, Gatske M. Nieuwenhuyzen-de Boer, Heleen J. van Beekhuizen, Angèle L.M. Oei, Annechien Bouman, Jojanneke van de Swaluw, Marchien van Baal, Sabrina Van Den Tillaart, Arnold‐Jan Kruse, Brenda Pijlman, Banut S. M. Verbruggen, David ten Cate, Rafli van de Laar, M.J.A. Engelen, Rafli van de Laar, M.J.A. Engelen
Topics & Concepts
MedicineHuman papillomavirusCervical intraepithelial neoplasiaAdjuvantInternal medicineVaccinationSurgeryClinical trialProphylactic treatmentIntraepithelial neoplasiaGynecologyRandomized controlled trialOncologyLesionCervical cancerDiseaseUterine cervixIncidence (geometry)PapillomaviridaeHPV vaccinesHuman papilloma virusYoung adultKoilocyteCervical Cancer and HPV ResearchGenital Health and DiseaseAI in cancer detection